---
id: ISO25539-2-2008
type: standard
schema_version: v1.4.1
title:
- language: en
  script: Latn
  content: Cardiovascular implants
  type: title-intro
  format: text/plain
- language: en
  script: Latn
  content: Endovascular devices
  type: title-main
  format: text/plain
- language: en
  script: Latn
  content: 'Part 2: Vascular stents'
  type: title-part
  format: text/plain
- language: en
  script: Latn
  content: 'Cardiovascular implants - Endovascular devices - Part 2: Vascular stents'
  type: main
  format: text/plain
- language: fr
  script: Latn
  content: Implants cardiovasculaires
  type: title-intro
  format: text/plain
- language: fr
  script: Latn
  content: Dispositifs endovasculaires
  type: title-main
  format: text/plain
- language: fr
  script: Latn
  content: 'Partie 2: Stents vasculaires'
  type: title-part
  format: text/plain
- language: fr
  script: Latn
  content: 'Implants cardiovasculaires - Dispositifs endovasculaires - Partie 2: Stents
    vasculaires'
  type: main
  format: text/plain
source:
- type: src
  content: https://www.iso.org/standard/35887.html
- type: rss
  content: https://www.iso.org/contents/data/standard/03/58/35887.detail.rss
docidentifier:
- content: ISO 25539-2:2008
  type: ISO
  primary: true
- content: ISO 25539-2:2008(E)
  type: iso-reference
- content: urn:iso:std:iso:25539:-2:stage-95.99
  type: URN
docnumber: '25539'
date:
- type: published
  at: 2008-09
contributor:
- role:
  - type: publisher
  organization:
    uri:
    - content: www.iso.org
    name:
    - content: International Organization for Standardization
    abbreviation:
      content: ISO
edition:
  content: '1'
language:
- en
- fr
script:
- Latn
abstract:
- language: en
  script: Latn
  content: |-
    ISO 25539-2:2008 specifies requirements for vascular stents, based upon current medical knowledge. With regard to safety, it gives requirements for intended performance, design attributes, materials, design evaluation, manufacturing, sterilization packaging and information supplied by the manufacturer. It should be considered as a supplement to ISO 14630, which specifies general requirements for the performance of non-active surgical implants.
    The scope of ISO 25539-2:2008 includes vascular stents used to treat vascular lesions or stenoses, or other vascular abnormalities. These devices might or might not incorporate surface modifications of the stent such as drug and/or other coatings. Stents covered with materials that significantly modify the permeability of the uncovered stent are within the scope of ISO 25539-1:2003. The stent design might dictate the need to address functional requirements identified in both ISO 25539-1:2003 and ISO 25539-2:2008.
    Delivery systems are included in ISO 25539-2:2008 if they comprise an integral component of the deployment of the vascular stent.
    Some pharmacological aspects of drug eluting stents are addressed in ISO 25539-2:2008, but this document is not comprehensive with respect to the pharmacological evaluation of drug eluting stents.
    With the exception of sterilization, ISO 25539-2:2008 does not address requirements for the evaluation of animal tissue products.
- language: fr
  script: Latn
  content: |-
    L'ISO 25539-2:2008 spécifie les exigences relatives aux stents vasculaires selon les connaissances médicales actuelles. En ce qui concerne la sécurité, elle donne les exigences relatives aux performances attendues, aux caractéristiques de conception, aux matériaux, à l'évaluation de la conception, à la fabrication, à la stérilisation, à l'emballage et aux informations fournies par le fabricant. Il convient de la considérer comme un complément à l'ISO 14630 qui spécifie les exigences générales relatives aux performances des implants chirurgicaux non actifs.
    Le domaine d'application de l'ISO 25539-2:2008 inclut les stents utilisés dans le traitement des lésions vasculaires ou sténoses, ou d'autres anomalies vasculaires. Ces dispositifs peuvent comprendre ou non, des modifications de surface du stent telles qu'un revêtement renfermant ou non un médicament. Les stents recouverts de matériaux qui modifient sensiblement l'étanchéité du stent nu sont compris dans le domaine d'application de l'ISO 25539-1:2003. La conception des stents peut rendre nécessaire d'analyser les exigences fonctionnelles identifiées à la fois dans l'ISO 25539-1:2003 et dans l'ISO 25539-2:2008.
    Les systèmes d'injection sont inclus dans l'ISO 25539-2:2008 s'ils comprennent un composant intégral du déploiement du stent vasculaire.
    Certains aspects pharmacologiques des stents à élution de médicaments sont traités dans l'ISO 25539-2:2008, mais celle-ci ne détaille pas l'évaluation pharmacologique de ce type de stent.
    À l'exception de la stérilisation, l'ISO 25539-2:2008 ne traite pas les exigences relatives à l'évaluation des produits de tissus animaux.
status:
  stage:
    content: '95'
  substage:
    content: '99'
copyright:
- from: '2008'
  owner:
  - organization:
      name:
      - content: ISO
relation:
- type: updates
  bibitem:
    type: standard
    formattedref: ISO 25539-2:2012
    docidentifier:
    - content: ISO 25539-2:2012
      type: ISO
      primary: true
    date:
    - type: circulated
      at: '2012-12-05'
place:
- formatted_place: Geneva
ext:
  schema_version: v1.0.5
  doctype:
    content: international-standard
  flavor: iso
  editorialgroup:
    technical_committee:
    - number: 150
      type: TC
      identifier: ISO/TC 150/SC 2
      content: Cardiovascular implants and extracorporeal systems
  ics:
  - code: 11.040.40
    text: Implants for surgery, prosthetics and orthotics
  structuredidentifier:
    type: ISO
    project_number:
      content: '35887'
